Aldo-keto reductase family 1, member B10 is secreted through a lysosome-mediated non-classical pathway

Biochemical Journal

Volumn 438, Issue 1, 2011, Pages 71-80

  Luo, Di Xian ^a,b   Huang, Mei C ^c   Ma, Jun ^a   Gao, Zachary ^a   Liao, Duan Fang ^b,d   Cao, Deliang ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CHINA   (China)

^c MEMORIAL MEDICAL CENTER   (United States)

^d HUNAN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Aldo keto reductase family 1; ATP binding cassette transporter (ABC transporter); Calcium signalling; Cancer marker; Lysosomal exocytosis; Member B10 (AKR1B10); Non classical protein secretion pathway

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; ADENOSINE TRIPHOSPHATE; ALDO KETO REDUCTASE FAMILY 1 MEMBER B10; BREFELDIN A; CALCIUM ION; CATHEPSIN D; CYCLOHEXIMIDE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); IONOMYCIN; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ARTICLE; CANCER CELL; CELL CULTURE; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; LYSOSOME; PRIORITY JOURNAL; PROTEIN SECRETION; TEMPERATURE; WESTERN BLOTTING;

ADENOCARCINOMA; ADENOSINE TRIPHOSPHATE; ALDEHYDE REDUCTASE; BLOTTING, WESTERN; BREAST NEOPLASMS; CALCIUM; CARCINOMA, BASAL CELL; COLORECTAL NEOPLASMS; CULTURE MEDIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXOCYTOSIS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINES; KIDNEY; LYSOSOMES;

EID: 79960761117     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20110111     Document Type: Article

References (78)

1. Cao, D., Fan, S. T. and Chung, S. S. (1998) Identification and characterization of a novel human aldose reductase-like gene. J. Biol. Chem. 273, 11429-11435
2. Petrash, J. M. (2004) All in the family: aldose reductase and closely related aldo-keto reductases. Cell. Mol. Life Sci. 61, 737-749
3. Srivastava, S. K., Das, B., Hair, G. A., Gracy, R. W., Awasthi, S., Ansari, N. H. and Petrash, J. M. (1985) Interrelationships among human aldo-keto reductases: immunochemical, kinetic and structural properties. Biochim. Biophys. Acta 840, 334-343
4. Jez, J. M., Flynn, T. G. and Penning, T. M. (1997) A nomenclature system for the aldo-keto reductase superfamily. Adv. Exp. Med. Biol. 414, 579-600
5. Hyndman, D., Bauman, D. R., Heredia, V. V. and Penning, T. M. (2003) The aldo-keto reductase superfamily homepage. Chem. Biol. Interact. 143-144, 621-631
6. Lee, K. W., Ko, B. C., Jiang, Z., Cao, D. and Chung, S. S. (2001) Overexpression of aldose reductase in liver cancers may contribute to drug resistance. Anticancer Drugs 12, 129-132 (Pubitemid 32207361)
7. Penning, T. M. and Drury, J. E. (2007) Human aldo-keto reductases: function, gene regulation, and single nucleotide polymorphisms. Arch. Biochem. Biophys. 464, 241-250
8. Barski, O. A., Tipparaju, S. M. and Bhatnagar, A. (2008) The aldo-keto reductase superfamily and its role in drug metabolism and detoxification. Drug Metab. Rev. 40, 553-624
9. Martin, H. J. and Maser, E. (2009) Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes. Chem. Biol. Interact. 178, 145-150
10. Shen, Y., Zhong, L., Markwell, S. and Cao, D. (2010) Thiol-disulfide exchanges modulate aldo-keto reductase family 1 member B10 activity and sensitivity to inhibitors. Biochimie 92, 530-537
11. Spite, M., Baba, S. P., Ahmed, Y., Barski, O. A., Nijhawan, K., Petrash, J. M., Bhatnagar, A. and Srivastava, S. (2007) Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes. Biochem. J. 405, 95-105 (Pubitemid 46999929)
12. Yan, R., Zu, X., Ma, J., Liu, Z., Adeyanju, M. and Cao, D. (2007) Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: implication for cancer intervention. Int. J. Cancer 121, 2301-2306 (Pubitemid 47585613)
13. Zhong, L., Liu, Z., Yan, R., Johnson, S., Zhao, Y., Fang, X. and Cao, D. (2009) Aldo-keto reductase family 1 B10 protein detoxifies dietary and lipid-derived α,β-unsaturated carbonyls at physiological levels. Biochem. Biophys. Res. Commun. 387, 245-250
14. Balendiran, G. K. (2009) Fibrates in the chemical action of daunorubicin. Curr. Cancer Drug Targets 9, 366-369
15. Shen, Y., Zhong, L., Johnson, S. and Cao, D. (2011) Human aldo-keto reductases 1B1 and 1B10: a comparative study on their enzyme activity toward electrophilic carbonyl compounds. Chem. Biol. Interact. 191, 192-198
16. Zu, X., Yan, R., Robbins, S., Krishack, P. A., Liao, D. F. and Cao, D. (2007) Reduced 293T cell susceptibility to acrolein due to aldose reductase-like-1 protein expression. Toxicol. Sci. 97, 562-568
17. Hashimoto, M., Sibata, T., Wasada, H., Toyokuni, S. and Uchida, K. (2003) Structural basis of protein-bound endogenous aldehydes. Chemical and immunochemical characterizations of configurational isomers of a 4-hydroxy-2-nonenal-histidine adduct. J. Biol. Chem. 278, 5044-5051
18. Okada, K., Wangpoengtrakul, C., Osawa, T., Toyokuni, S., Tanaka, K. and Uchida, K. (1999) 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules. J. Biol. Chem. 274, 23787-23793
19. De Bont, R. and van Larebeke, N. (2004) Endogenous DNA damage in humans: a review of quantitative data. Mutagenesis 19, 169-185 (Pubitemid 38744825)
20. Eder, E., Scheckenbach, S., Deininger, C. and Hoffman, C. (1993) The possible role of α,β-unsaturated carbonyl compounds in mutagenesis and carcinogenesis. Toxicol. Lett. 67, 87-103
21. Choudhary, S., Xiao, T., Srivastava, S., Zhang, W., Chan, L. L., Vergara, L. A., Van Kuijk, F. J. and Ansari, N. H. (2005) Toxicity and detoxification of lipid-derived aldehydes in cultured retinal pigmented epithelial cells. Toxic. Appl. Pharm. 204, 122-134
22. Crosas, B., Hyndman, D. J., Gallego, O., Martras, S., Pares, X., Flynn, T. G. and Farres, J. (2003) Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism. Biochem. J. 373, 973-979 (Pubitemid 36981109)
23. Gallego, O., Belyaeva, O. V., Porte, S., Ruiz, F. X., Stetsenko, A. V., Shabrova, E. V., Kostereva, N. V., Farres, J., Pares, X. and Kedishvili, N. Y. (2006) Comparative functional analysis of human medium-chain dehydrogenases, short-chain dehydrogenases/ reductases and aldo-keto reductases with retinoids. Biochem. J. 399, 101-109
24. Gallego, O., Ruiz, F. X., Ardevol, A., Dominguez, M., Alvarez, R., de Lera, A. R., Rovira, C., Farres, J., Fita, I. and Pares, X. (2007) Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10. Proc. Natl. Acad. Sci. U.S.A. 104, 20764-20769
25. Wang, C., Yan, R., Luo, D., Watabe, K., Liao, D. F. and Cao, D. (2009) Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls. J. Biol. Chem. 284, 26742-26748
26. Ma, J., Yan, R., Zu, X., Cheng, J. M., Rao, K., Liao, D. F. and Cao, D. (2008) Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-α in breast cancer cells. J. Biol. Chem. 283, 3418-3423
27. Yoshitake, H., Takahashi, M., Ishikawa, H., Nojima, M., Iwanari, H., Watanabe, A., Aburatani, H., Yoshida, K., Ishi, K., Takamori, K. et al. (2007) Aldo-keto reductase family 1, member B10 in uterine carcinomas: a potential risk factor of recurrence after surgical therapy in cervical cancer. Int. J. Gynecol. Cancer 17, 1300-1306
28. Fukumoto, S., Yamauchi, N., Moriguchi, H., Hippo, Y., Watanabe, A., Shibahara, J., Taniguchi, H., Ishikawa, S., Ito, H., Yamamoto, S. et al. (2005) Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas. Clin. Cancer Res. 11, 1776-1785
29. Wang, R., Wang, G., Ricard, M. J., Ferris, B., Strulovici-Barel, Y., Salit, J., Hackett, N. R., Gudas, L. J. and Crystal, R. G. (2010) Smoking-induced upregulation of AKR1B10 expression in the airway epithelium of healthy individuals. Chest 138, 1402-1410
30. Quinn, A. M., Harvey, R. G. and Penning, T. M. (2008) Oxidation of PAH trans-dihydrodiols by human aldo-keto reductase AKR1B10. Chem. Res. Toxicol. 21, 2207-2215
31. Li, C. P., Goto, A., Watanabe, A., Murata, K., Ota, S., Niki, T., Aburatani, H. and Fukayama, M. (2008) AKR1B10 in usual interstitial pneumonia: expression in squamous metaplasia in association with smoking and lung cancer. Pathol. Res. Pract. 204, 295-304
32. Penning, T. M. (2005) AKR1B10: a new diagnostic marker of non-small cell lung carcinoma in smokers. Clin. Cancer Res. 11, 1687-1690
33. Huang, L. J., Chen, S. X., Huang, Y., Luo, W. J., Jiang, H. H., Hu, Q. H., Zhang, P. F. and Yi, H. (2006) Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer. Lung Cancer 54, 87-94
34. Pailhoux, E. A., Martinez, A., Veyssiere, G. M. and Jean, C. G. (1990) Androgen-dependent protein from mouse vas deferens. cDNA cloning and protein homology with the aldo-keto reductase superfamily. J. Biol. Chem. 265, 19932-19936
35. Andrei, C., Dazzi, C., Lotti, L., Torrisi, M. R., Chimini, G. and Rubartelli, A. (1999) The secretory route of the leaderless protein interleukin 1β involves exocytosis of endolysosome-related vesicles. Mol. Biol. Cell 10, 1463-1475
36. Nickel, W. (2003) The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur. J. Biochem. 270, 2109-2119
37. Mor-Vaknin, N., Punturieri, A., Sitwala, K. and Markovitz, D. M. (2003) Vimentin is secreted by activated macrophages. Nat. Cell Biol. 5, 59-63
38. Johansson, A. C., Nandakumar, K. S., Persson, A. M., Olsson, I. and Hansson, M. (2009) Secretory lysosome targeting and induced secretion of human soluble TNF-α receptor in murine hematopoietic cells in vivo as a principle for immunoregulation in inflammation and malignancy. Exp. Hematol. 37, 969-978
39. Mambula, S. S. and Calderwood, S. K. (2006) Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes. J. Immunol. 177, 7849-7857
40. 7 nucleotide receptor in monocytes, macrophages, and HEK-293 cells. Am. J. Physiol. 285, C286-C299
41. Di Virgilio, F., Chiozzi, P., Ferrari, D., Falzoni, S., Sanz, J. M., Morelli, A., Torboli, M., Bolognesi, G. and Baricordi, O. R. (2001) Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97, 587-600
42. 2+ -regulated exocytic vesicles in fibroblasts and epithelial cells. J. Cell Biol. 137, 93-104
43. 2+ influx in rat thymic lymphocytes. Biochem. J. 296, 33-39
44. Tapper, H. and Sundler, R. (1990) Role of lysosomal and cytosolic pH in the regulation of macrophage lysosomal enzyme secretion. Biochem. J. 272, 407-414
45. 4Cl: role of depressed activities of cathepsins due to elevated lysosomal pH. Kidney Int. 53, 1706-1712
46. Cockcroft, S. (1990) G-proteins and exocytotic secretion in phagocytic cells. FEMS Microbiol. Immunol. 2, 3-8
47. Cockcroft, S. (1997) Phosphatidylinositol transfer proteins: requirements in phospholipase C signaling and in regulated exocytosis. FEBS Letters 410, 44-48
48. Cockcroft, S. (1998) Phosphatidylinositol transfer proteins: a requirement in signal transduction and vesicle traffic. Bioessays 20, 423-432
49. Jones, D., Morgan, C. and Cockcroft, S. (1999) Phospholipase D and membrane traffic. Potential roles in regulated exocytosis, membrane delivery and vesicle budding. Biochim. Biophys. Acta 1439, 229-244
50. Cockcroft, S. and Stutchfield, J. (1988) Effect of pertussis toxin and neomycin on G-protein-regulated polyphosphoinositide phosphodiesterase. A comparison between HL60 membranes and permeabilized HL60 cells. Biochem. J. 256, 343-350
51. Berridge, M. J. (1993) Inositol trisphosphate and calcium signaling. Nature 361, 315-325
52. Fensome, A., Cunningham, E., Prosser, S., Tan, S. K., Swigart, P., Thomas, G., Hsuan, J. and Cockcroft, S. (1996) ARF and PITP restore GTPγS-stimulated protein secretion from cytosol-depleted HL60 cells by promoting PIP2 synthesis. Curr. Biol. 6, 730-738
53. Feng, Y., Yu, S., Lasell, T. K., Jadhav, A. P., Macia, E., Chardin, P., Melancon, P., Roth, M., Mitchison, T. and Kirchhausen, T. (2003) Exo1: a new chemical inhibitor of the exocytic pathway. Proc. Natl. Acad. Sci. U.S.A. 100, 6469-6474
54. Hamon, Y., Luciani, M. F., Becq, F., Verrier, B., Rubartelli, A. and Chimini, G. (1997) Interleukin-1β secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1. Blood 90, 2911-2915 (Pubitemid 27444184)
55. Bottger, A., Strasser, D., Alexandrova, O., Levin, A., Fischer, S., Lasi, M., Rudd, S. and David, C. N. (2006) Genetic screen for signal peptides in Hydra reveals novel secreted proteins and evidence for non-classical protein secretion. Eur. J. Cell Biol. 85, 1107-1117
56. Bendtsen, J. D., Jensen, L. J., Blom, N., Von Heijne, G. and Brunak, S. (2004) Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng. Des. Sel. 17, 349-356
57. Cleves, A. E., Cooper, D. N., Barondes, S. H. and Kelly, R. B. (1996) A new pathway for protein export in Saccharomyces cerevisiae. J. Cell Biol. 133, 1017-1026
58. Duran, J. M., Anjard, C., Stefan, C., Loomis, W. F. and Malhotra, V. (2010) Unconventional secretion of Acb1 is mediated by autophagosomes. J. Cell Biol. 188, 527-536
59. Cabral, M., Anjard, C., Malhotra, V., Loomis, W. F. and Kuspa, A. (2010) Unconventional secretion of AcbA in Dictyostelium discoideum through a vesicular intermediate. Eukary. Cell 9, 1009-1017
60. Andrei, C., Margiocco, P., Poggi, A., Lotti, L. V., Torrisi, M. R. and Rubartelli, A. (2004) Phospholipases C and A2 control lysosome-mediated IL-1β secretion: implications for inflammatory processes. Proc. Natl. Acad. Sci. U.S.A. 101, 9745-9750
61. Cohen, L. A., Gutierrez, L., Weiss, A., Leichtmann-Bardoogo, Y., Zhang, D. L., Crooks, D. R., Sougrat, R., Morgenstern, A., Galy, B., Hentze, M. W. et al. (2010) Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood 116, 1574-1584
62. Gardella, S., Andrei, C., Ferrera, D., Lotti, L. V., Torrisi, M. R., Bianchi, M. E. and Rubartelli, A. (2002) The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Reports 3, 995-1001 (Pubitemid 35256475)
63. Gao, Y., Hansson, M., Calafat, J., Tapper, H. and Olsson, I. (2004) Sorting soluble tumor necrosis factor (TNF) receptor for storage and regulated secretion in hematopoietic cells. J. Leukoc. Biol. 76, 876-885
64. 2+ -regulated exocytosis of lysosomes. Cell 106, 157-169
65. Qu, Y., Franchi, L., Nunez, G. and Dubyak, G. R. (2007) Nonclassical IL-1β secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J. Immunol. 179, 1913-1925
66. 2+ signaling in macrophages. J. Biol. Chem. 281, 35147-35155
67. 7 receptors. J. Biol. Chem. 276, 125-132
68. Eder, C. (2009) Mechanisms of interleukin-1β release. Immunobiology 214, 543-553
69. Lubke, T., Lobel, P. and Sleat, D. E. (2009) Proteomics of the lysosome. Biochim. Biophys. Acta 1793, 625-635
70. Obermuller, S., Kiecke, C., von Figura, K. and Honing, S. (2002) The tyrosine motifs of Lamp 1 and LAP determine their direct and indirect targeting to lysosomes. J. Cell Sci. 115, 185-194 (Pubitemid 34105541)
71. Eskelinen, E. L. (2006) Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol. Aspects Med. 27, 495-502
72. Nirde, P., Derocq, D., Maynadier, M., Chambon, M., Basile, I., Gary-Bobo, M. and Garcia, M. (2010) Heat shock cognate 70 protein secretion as a new growth arrest signal for cancer cells. Oncogene 29, 117-127
73. Warren, L. (1990) Stimulation of lysosomal enzyme secretion by growth factors. Exp. Cell Res. 190, 133-136
74. Abbott, D. E., Margaryan, N. V., Jeruss, J. S., Khan, S., Kaklamani, V., Winchester, D. J., Hansen, N., Rademaker, A., Khalkhali-Ellis, Z. and Hendrix, M. J. (2010) Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology. Cancer Biol. Ther. 9, 23-30
75. Soderberg, A., Sahaf, B. and Rosen, A. (2000) Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma. Cancer Res. 60, 2281-2289 (Pubitemid 30225195)
76. Martinez, A., Pailhoux, E., Berger, M. and Jean, C. (1990) Androgen regulation of the mRNA encoding a major protein of the mouse vas deferens. Mol. Cell. Endocrinol. 72, 201-211
77. Ruiz, F. X., Gallego, O., Ardevol, A., Moro, A., Dominguez, M., Alvarez, S., Alvarez, R., de Lera, A. R., Rovira, C., Fita, I. et al. (2009) Aldo-keto reductases from the AKR1B subfamily: retinoid specificity and control of cellular retinoic acid levels. Chem. Biol. Interact. 178, 171-177
78. Bartsch, H. and Nair, J. (2004) Oxidative stress and lipid peroxidation-derived DNA-lesions in inflammation driven carcinogenesis. Cancer Detect. Prev. 28, 385-391